Serologic assays using crude antigens for the diagnosis of visceral leishmaniasis in human immunodeficiency virus type 1 (HIV) -seropositive patients have been shown to lack sensitivity and specificity, particularly in AIDS patients. Antibodies to a cloned antigen, recombinant (r) K39, of Leishmania chagasi are specific for members of the Leishmania donovani complex and have been shown to indicate active disease in immunocompetent persons. This study demonstrated that antibodies to rK39 were also detectable in HIV-seropositive patients coinfected with Leishmania infantum. Furthermore, the rK39 ELISA was more sensitive than an IFA for detecting L. infantum infections in patients with AIDS. In addition, antibody titers to rK39 in HIV-negative patients infected with L. infantum or L. chagasi declined during treatment with meglumine antimoniate or liposomal amphotericin B. In contrast, most patients who clinically relapsed showed increased antibody titers to rK39. These data demonstrate the diagnostic and prognostic utility of rK39 in detecting active visceral leishmaniasis.
The incidence of leishmaniasis as an opportunistic infection tients have been shown to be parasite positive but seronegative by IFA or other commonly used serologic techniques [12 -14] . in AIDS patients in southern Europe has increased substantially Therefore, diagnosis must rely on invasive techniques (i.e., the since the first case of human immunodeficiency virus type 1 demonstration of parasites in bone marrow or splenic aspirates (HIV) -leishmaniasis coinfection was described in 1985 [1] . or in mucosal biopsies) [2, 7] . Several hundred cases have now been identified in Italy, A recombinant (r) antigen, rK39, has been shown to be France, Spain, and Portugal [2 -4] . The diagnosis of coinfection specific for antibodies arising during VL caused by members of in AIDS patients is difficult because they often have unusual the Leishmania donovani complex, which include Leishmania clinical manifestations of visceral leishmaniasis (VL) [5 -7] .
chagasi (Latin America) and L. infantum (Europe) [15] . This In these cases, the infectious agent is Leishmania infantum, antigen, which is a member of the kinesin family, is highly which is primarily associated with VL but in some cases, may sensitive and predictive for onset of acute disease, and high also cause a cutaneous form of the disease. Thus, L. infantum antibody titers (10 4 -10 6 ) have been demonstrated in HIV-negahas been shown to exhibit tropism, and different zymodemes tive persons [16 -18] . In this study, we compare the sensitivity have been shown to be associated with these different forms of an ELISA using rK39 antigen with the sensitivity of a stanof the disease [8] . Furthermore, heterogeneity among these dard IFA for detecting anti-Leishmania antibodies in Italian zymodemes has been demonstrated in many HIV-positive pa-HIV-1 -infected patients with parasitologically confirmed VL. tients with VL in southern Italy [9] .
Another desirable aspect of rK39 is that antibody titers to Serologic testing, which is highly predictive in immunocomthis antigen directly correlate with active disease, indicating petent patients with Mediterranean VL [10, 11], has had varying the potential use of rK39 as a means of monitoring chemotherresults in patients coinfected with HIV because of the low apy [16] . Several drugs are now available for treating leishmalevels of anti-Leishmania antibodies. In many cases, these pa- 
Materials and Methods
determined from the serum dilution with an OD of Ç0.3, correPatient groups. Sera from 56 HIV-positive patients shown to sponding to the cutoff value typically encountered at a 1/50 dilution be coinfected with L. infantum by microscopy and by culture of of serum. The cutoff was determined to be the mean / 3 SD of a bone marrow aspirate were tested by ELISA, using rK39 recomnegative control samples. binant antigen, and by IFA. As a control group, 9 random donor sera and sera from 12 HIV-seropositive US patients with no exposure to L. infantum were tested.
Results
In a second study group, patients treated with meglumine antimoniate (MAM, Glucantime; Rhone Poulenc Rorer, Paris) or lipoDiagnosis of VL in HIV-infected persons can be problem- by ELISA, using recombinant rK39 as the solid phase, and by obtained over treatment periods ranging up to 9 months (table  2) . Parallel decreases in titers of antibodies to rK39 were also IFA. In particular, it was of interest to determine whether serum titers against rK39 decreased during successful treatment with observed, although they were typically higher than those for the IFA and were still significantly above cutoff when IFA the drugs, as this could indicate the relationship between titers to rK39 and parasite burden. It was also important to establish values were at the cutoff level of 1/80. Comparable declines in titers for IFAs and anti-rK39 antithe relationship of such changes to those manifested in the IFA to determine whether the rK39 ELISA would be useful for bodies were also seen when patients were treated with AmB (figure 2), further indicating the utility of the rK39 ELISA in monitoring drug therapy. The usual method to assess drug response in VL is repetition of a bone marrow aspirate at monitoring treatment with the antileishmanial drugs MAM and AmB. The mean titers for the IFA and rK39 ELISA were days 21 -28 after treatment initiation. All patients in this study, including those that relapsed, had a negative bone marrow test determined for all patients being treated with MAM or AmB for each of the time points 0, 3, 6, and 9 months. The time at this time. It is also common procedure to avoid further invasive examination after this period when the patient shows course of treatment with both drugs indicated that they led to similar rates of decline in IFA titers and rK39 antibody titers. evidence of clinical recovery. Therefore, follow-up procedures after 1 month of treatment are only clinical evaluation and After a 9 month regimen, the titers for both IFA and rK39 antibodies were still positive (figure 2). After 9 months, rK39 serology.
Of the 6 patients undergoing treatment with MAM, all demmean ELISA titers of 865 (AmB) and 4265 (MAM) were considerably higher than the cutoff of 1/50, whereas IFA titers of onstrated significant decreases in IFA titers in serum samples 120 (AmB) and 448 (MAM) were only 1.5-to 5.5-fold above the cutoff of 1/80. The third study group involved 8 patients who relapsed while undergoing anti-Leishmania treatment. In this group, there 6 cases, the change in rK39 titer essentially paralleled the were also correlations between the IFA and the rK39 ELISA decreases and increases in titers seen in the IFA (table 3) , with results. After relapse, clinical and laboratory parameters and the rK39 titer again being much higher than that for the IFA. parasite burden for this group did not differ significantly from
In the other 2 cases (serum identifications 208 and 215 in table those for patients successfully cured with AmB or MAM. In 3), there were slight differences in that the titer for rK39 did not rise in unison with the titer for IFA after relapse; however, in both cases, the rK39 ELISA result was clearly positive. Because a 2-fold increase in IFA titer is a marginal increase, this may or may not indicate differences in the ability of the two assays to accurately predict relapse. Finally, the fourth study group involved 6 patients infected with L. chagasi who were undergoing treatment with antimonials. They were also shown to have antibody titers to rK39 that decreased during chemotherapy ( figure 3) . In most cases, the reduction in titer was achieved even with widely differing rK39 titers prior to treatment. In all cases, the rK39 ELISA was positive for antibody even after 12 months. In addition, rK39 antibody titers seen in L. chagasi infections were typically less than those seen with L. infantum infection. values. Among 330 sera from patients examined in the last 10 diagnostic efficacy (83%) has been reported for a dot blotting technique developed with crude L. infantum antigen in combiyears at the Istituto Superiore di Sanità, the IFA detected antiLeishmania antibodies at titers §1:80 in 328 samples (99.4%) nation with IFA and Western blotting with the 14-and 16-kDa bands [23, 24] . Thus, in relation to these other test procedures, [13] . Recently, 99% sensitivity has been reported for rK39 antigen in the diagnosis of acute VL in 135 subjects [16] .
Discussion
rK39 provides an advantage, combining a relatively high sensitivity (82%) and full reproducibility when used to test immunoIn the present study, the rK39 ELISA was compared with the IFA in detecting anti-Leishmania antibodies in persons compromised patients for coinfection with VL. Patients infected with L. infantum alone and undergoing coinfected with HIV and L. infantum. Compared with the IFA, the rK39 antigen assay was more effective in detecting antitreatment with MAM or AmB had changes in serum titers to rK39 that reflected those observed in the IFA. However, beLeishmania antibodies in VL patients with AIDS (i.e., the group of patients showing a higher degree of immunosupprescause of the higher titers to rK39, reactivity was still detectable even when IFA values were close to or below the cutoff of 1/ sion); however, the rK39 ELISA was only slightly more effective than the IFA in detecting antibodies in HIV-1 -seropositive 80. This would suggest that elimination of antibodies to rK39 would be a more effective predictor than IFA titers of the persons without AIDS. Overall, the rK39 ELISA had a sensitivity of 82.1% in persons coinfected with HIV and Leishmania success of treatment with MAM and AmB. Similar changes in rK39 antibody titers were also observed in patients with L. species, compared with 53.6% for the IFA. Using a commercial IFA kit, Mantalban et al. [12] showed sensitivity of the assay chagasi infections undergoing treatment, confirming the utility of rK39 EIA in monitoring treatment due to other parasites of to be as low as 38% among 29 sera from HIV patients with VL. Sensitivity of this test increased when fresh laboratorythe L. donovani complex.
Six of the 8 patients who had clinical relapses resulting in prepared antigen was used [13] . An ELISA using crude Leishmania antigen was as sensitive as the IFA (55%) [14] . Higher increased IFA values also had a corresponding change in rK39
